SAREPTA THERAPEUTICS, INC. Income (Loss) from Equity Method Investments
SAREPTA THERAPEUTICS, INC. (SRPT) reported Income (Loss) from Equity Method Investments of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2026-03-02
- SAREPTA THERAPEUTICS, INC. income (loss) from equity method investments for the quarter ending 2024-12-31 was $0.00.
- SAREPTA THERAPEUTICS, INC. income (loss) from equity method investments for the quarter ending 2023-12-31 was -$2.50M.
- SAREPTA THERAPEUTICS, INC. income (loss) from equity method investments for fiscal 2025 was $0.00.
- SAREPTA THERAPEUTICS, INC. income (loss) from equity method investments for fiscal 2024 was $0.00.
- SAREPTA THERAPEUTICS, INC. income (loss) from equity method investments for fiscal 2023 was -$30.32M.
- SAREPTA THERAPEUTICS, INC. income (loss) from equity method investments for fiscal 2022 was -$2.58M.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month |
|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-02 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $0.00 10-K · filed 2026-03-02 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-06 | ||
| 2023-12-31 | -$2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$30.32M 10-K · filed 2026-03-02 | |
| 2023-09-30 | -$27.82M 10-Q · filed 2024-11-06 | ||
| 2022-12-31 | -$2.58M 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |